We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > drug candidates

News List

Eleva Enters Clinical Development of Difficult-To-Express High-Potential Proteins prnasia
October 13, 2021
Eleva, a manufacturer of superior biologics, is entering clinical phases with its own drug candidates, such as immune-regulating factor H, as well as in collaboration with pharmaceutical partners.
SOM Biotech identifies three Covid-19 drug candidates pharmaceutical-technology
April 23, 2020
SOM Biotech has completed in-vitro analyses and identified three drug candidates that can be potentially used to treat Covid-19.
BiomX raises funds to advance drug candidates for acne and IBD pharmaceutical-technology
February 22, 2019
Israeli drug discovery firm BiomX has raised funds in a series B round to advance its lead acne and inflammatory bowel disease (IBD) drug programmes to the clinic.....
CANbridge Pharmaceuticals expands partnership with Wuxi Biologics pharmaceutical-technology
January 11, 2019
China’s CANbridge Pharmaceuticals has expanded its alliance with WuXi Biologics for the discovery, development and commercialisation of four additional drug candidates to potentially treat rare genetic chronic diseases.....